Atomfair Brainwave Hub: SciBase II / Artificial Intelligence and Machine Learning / AI-driven drug discovery and synthesis

AI-driven drug discovery and synthesis

Showing 205-216 of 245 articles

Optimizing CRISPR-Cas12a gene editing for high-specificity mitochondrial DNA modifications

Targeting prion disease reversal via CRISPR-based gene editing and protein misfolding inhibitors

Inflammasome inhibition strategies for chronic neurodegenerative disease intervention using art-inspired biomolecules

Across axonal propagation delays, measuring neural synchronization in neurodegenerative diseases

Optimizing neurotransmitter release events for targeted drug delivery in Parkinson's disease

Advancing senolytic drug discovery with high-throughput screening in femtoliter volumes

Flow chemistry robots for scalable synthesis of patent-expired pharmaceutical innovations

Automated retrosynthesis platforms for rapid drug discovery using AI and quantum computing

Aligning flow chemistry robots with 2035 SDG targets for pharmaceutical democratization

For automated retrosynthesis: integrating reinforcement learning with chemical knowledge graphs

Breakthroughs in Alzheimer's treatment via century-long clinical trials and multi-omics integration

Marrying psychedelic research with neural decoding to map consciousness pathways